Table 4

Cost-effectiveness results for a cohort of 1000 patients, where the percentage of placebo patients returning for PCI within 1 year is varied

Scenario: per cent crossing over from placeboTotal costsTotal QALYsCost difference*QALY difference*ICER†
20£740 538797.87£1 254 88015.791£79 469
40£1 070 460799.815£924 95813.846£66 804
60£1 399 549802.023£595 86911.637£51 203
80£1 725 707804.751£269 7118.91£30 271
  • *Compared with the PCI group.

  • †ICER calculated prior to rounding.

  • ICER, incremental cost-effectiveness ratio; PCI, percutaneous coronary intervention; QALYs, quality-adjusted life-years.